MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Prolium Bioscience, Inc.
Finance & Acquisition: Prolium Bioscience
Parents
Prolium Bioscience, Inc.
Children
2025: Founded and backed by RTW Investments
2026: Prolium Bioscience Launches with $50 Million and Announces First Patients Dosed with PRO-203, a Potential Best-in-Class CD20xCD3 T-Cell Engager, for Severe Autoimmune Disease
Jumps
Key People: Prolium Bioscience
Organization & Developments: Prolium Bioscience